Literature DB >> 1248951

Effect of clofibrate application on morphology and enzyme content of liver peroxisomes.

H Goldenberg, M Hüttinger, P Kampfer, R Kramar, M Pavelka.   

Abstract

Male albino rats (Sprague Dawley) were fed for 2-6 weeks on a diet containing 0.75% clofibrate. Liver cell fractions obtained from these animals were assayed for peroxisomal enzymes. In the cell homogenate the catalase activity was doubled, whereas the activity of urate oxidase was found to be only slightly depressed. The activity of carnitine acetyltransferase increased several times. In liver peroxisomes purified by isopycnic gradient centrifugation the specific activity of urate oxidase decreased appreciably showing that peroxisomes formed under the proliferative influence of clofibrate are not only modified with respect to their morphological characteristics but also to their enzymic equipment. This is also obvious from the changes in peroxisomal carnitine acetyltransferase activity which was enhanced by clofibrate to more than the fivefold amount. In purified mitochondria this enzyme was even more active: clofibrate advances both, the peroxisomal and the mitochondrial moiety of carnitine acetyltransferase. Morphological and cytochemical studies showed an increase in the number of microbodies and as compared to the controls microbodies were lying in groups more frequently. Small particles located closely adjacent to "normal" sized peroxisomes were found particularly after short feeding periods. While the number of coreless microbodies increased studies gave no clear evidence for an increase in marked shape irregularities of the peroxisomes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248951     DOI: 10.1007/bf02462782

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  22 in total

1.  Preparation and characterization of catalase-positive particles ('microperoxisomes') from Harder's gland of the rat.

Authors:  P Böck; H Goldenberg; M Hüttinger; M Kolar; R Kramar
Journal:  Exp Cell Res       Date:  1975-01       Impact factor: 3.905

2.  Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.

Authors:  H Hayashi; T Suga; S Ninobe
Journal:  J Biochem       Date:  1975-06       Impact factor: 3.387

Review 3.  Possible properties of microbodies (peroxisomes). Microbody proliferation and hypolipidemic drugs.

Authors:  J K Reddy
Journal:  J Histochem Cytochem       Date:  1973-11       Impact factor: 2.479

4.  Effects of catalase inhibitors on the ultrastructure and peroxidase activity of proliferating microbodies.

Authors:  P G Legg; R L Wood
Journal:  Histochemie       Date:  1970

5.  Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.

Authors:  D E Moody; J K Reddy
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-11

6.  The role of the thyroid hormone in the effect of p-chlorophenoxyisobutyrate in rats.

Authors:  W W Westerfeld; D A Richert; W R Ruegamer
Journal:  Biochem Pharmacol       Date:  1968-06       Impact factor: 5.858

7.  Improvements in epoxy resin embedding methods.

Authors:  J H LUFT
Journal:  J Biophys Biochem Cytol       Date:  1961-02

8.  Microbodies in experimentally altered cells. VII. CPID-induced hepatic microbody proliferation in the absence of significant catalase synthesis.

Authors:  J Reddy; M Chiga; S Bunyaratvej; D Svoboda
Journal:  J Cell Biol       Date:  1970-01       Impact factor: 10.539

9.  Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.

Authors:  D Svoboda; D Azarnoff; J Reddy
Journal:  J Cell Biol       Date:  1969-03       Impact factor: 10.539

10.  Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB).

Authors:  D J Svoboda; D L Azarnoff
Journal:  J Cell Biol       Date:  1966-08       Impact factor: 10.539

View more
  11 in total

1.  Enzymic and morphological studies on catalase positive particles from brown fat of cold adapted rats.

Authors:  M Pavelka; H Goldenberg; M Hüttinger; R Kramar
Journal:  Histochemistry       Date:  1976-11-19

2.  Comparative induction of cytochrome P450IVA1 and peroxisome proliferation by ciprofibrate in the rat and marmoset.

Authors:  J M Makowska; F W Bonner; G G Gibson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Catalase positive particles from pig lung. Biochemical preparations and morphological studies.

Authors:  H Goldenberg; M Hüttinger; U Kollner; R Kramar; M Pavelka
Journal:  Histochemistry       Date:  1978-07-12

4.  Nucleic acid synthesis in proliferating peroxisomes of rat liver as revealed by electron microscopical radioautography.

Authors:  T Nagata; S Ohno; K Yoshida; F Murata
Journal:  Histochem J       Date:  1982-03

5.  Bile formation and biliary lipid composition under the influence of clofibrate and phenobarbital pretreatment in the rat.

Authors:  K Kutz; A Schulte; C Just; H Lindstaedt; B Reiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-08       Impact factor: 3.000

6.  The effects of clofibrate ingestion on alveolar macrophage peroxisome content and oxygen metabolism.

Authors:  D B Drath; P Davies; J M Shorrey; P Simpson
Journal:  Agents Actions       Date:  1982-07

7.  The effect of feeding Di-(2-ethylhexyl) phthalate (DEHP) on the lipid metabolism of laying hens.

Authors:  D L Wood; J Bitman
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

8.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Authors:  P B Lazarow; C De Duve
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

9.  The proliferative response of hepatic peroxidomes of neonatal rats to treatment with SU-13 437 (nafenopin).

Authors:  W Stäubli; W Schweizer; J Suter; E R Weibel
Journal:  J Cell Biol       Date:  1977-09       Impact factor: 10.539

10.  Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.

Authors:  D J Svoboda
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.